SCHEMBL6692722

SCHEMBL6692722

CC(C)(N)C(=O)NCCN

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
CYP2C19 P33261 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PAOX Q6QHF9 2/20 0.35
POLB P06746 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
MAOB P27338 2/20 0.34
CYP1A2 P05177 1/20 0.34
TSHR P16473 1/20 0.34
NFKB1 P19838 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33
EPHX1 P07099 1/20 0.32
TACR1 P25103 1/20 0.32
TACR3 P29371 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL422608 0.83 POLB (0.44) ALDH1A1CYP2C9HPGDALOX15CYP2C19
SCHEMBL11957576 0.83 ALDH1A1 (0.37) ALDH1A1CYP2C9HPGDALOX15CYP2C19
SCHEMBL9501632 0.81 ALDH1A1 (0.36) ALDH1A1CYP2C9HPGDALOX15CYP2C19
SCHEMBL2745969 0.81 ALDH1A1 (0.39) ALDH1A1HSD17B10POLBSMN1; SMN2MEN1
SCHEMBL13887188 0.81 KDM4C (0.45) ALDH1A1PAOXPOLBSMN1; SMN2MEN1
SCHEMBL8352233 0.80
SCHEMBL23465665 0.79 ALDH1A1 (0.43) ALDH1A1CYP2C9HPGDALOX15CYP2C19
SCHEMBL14684132 0.79 ALDH1A1 (0.34) ALDH1A1CYP2C9HPGDALOX15CYP2C19
SCHEMBL14288774 0.79 PGK1 (0.34) ALDH1A1POLBSMN1; SMN2MEN1KMT2A
SCHEMBL2746170 0.79 KDM4E (0.46) ALDH1A1PAOXPOLBSMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040186160-A1 Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors SUGEN, INC. 2004-09-23 US disclosed
WO-2003101382-A2 COMPOUNDS USEFUL IN THE TREATMENT OF ANTHRAX AND INHIBITING LETHAL FACTOR MERCK & CO., INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186160-A1 Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors MAP3K15, MAP3K20, MAP3K19 ALDH1A1 3282/4885CYP2C9 3915/4885HPGD 1104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.